Hengrui Therapeutics, Inc. clinical trials
A subsidiary of Jiangsu HengRui Medicine Co., Ltd.
The registry lists 2 studies whose lead sponsor is Hengrui Therapeutics, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 1, 2021.
Registry sponsor names on this page
- Hengrui Therapeutics, Inc.2 studies
Something wrong with this grouping? Tell us on the Jiangsu HengRui Medicine Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Jiangsu HengRui Medicine Co., Ltd. studies →
- Phase I Study of Pyrotinib in Patients With HER2-positive Solid TumorsStatus unknownNCT02500199Phase 1
Sponsor listed in the registry: Hengrui Therapeutics, Inc.
- A Phase 1, Study to Evaluate HTI-2088 TabletCompletedNCT03203811Phase 1
Sponsor listed in the registry: Hengrui Therapeutics, Inc.